Camidge DR, Barlesi F, Goldman JW, Morgensztern D, et al. Phase Ib Study of Telisotuzumab Vedotin in Combination With Erlotinib in Patients With c-Met Protein-Expressing Non-Small-Cell Lung Cancer. J Clin Oncol 2022 Oct 26:JCO2200739. doi: 10.1200/JCO.22.00739.
PMID: 36288547